{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:23:23Z","timestamp":1791843803155,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-025-00818-8","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T01:30:55Z","timestamp":1745544655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The dynamic immune behavior of primary and metastatic ovarian carcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Elaine","family":"Stur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuduan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7919-3567","authenticated-orcid":false,"given":"Pang-ning","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Bayraktar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-2243","authenticated-orcid":false,"given":"Sara","family":"Corvigno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen N.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-9511","authenticated-orcid":false,"given":"Nicholas W.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2888-2968","authenticated-orcid":false,"given":"Kathleen M.","family":"Darcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4742-3281","authenticated-orcid":false,"given":"Thomas","family":"P. Conrads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"V\u00e1zquez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-523X","authenticated-orcid":false,"given":"Sohrab P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Celestino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"D. Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-8624","authenticated-orcid":false,"given":"Nicholas E.","family":"Navin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4242-1762","authenticated-orcid":false,"given":"Anil K.","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"818_CR1","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis, U. A. et al. Ovarian cancer. Nat. Rev. Dis. Prim. 2, 16061 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"818_CR2","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/cncr.33488","volume":"127","author":"MA Mullins","year":"2021","unstructured":"Mullins, M. A. et al. Trends and racial disparities in aggressive end-of-life care for a national sample of women with ovarian. Cancer Cancer 127, 2229\u20132237 (2021).","journal-title":"Cancer Cancer"},{"key":"818_CR3","unstructured":"Coalition Woc. The World Ovarian Cancer Coalition atlas. The Every Woman Study 2018. https:\/\/worldovariancancercoalition.org\/wp-content\/uploads\/2018\/10\/THE-WORLD-OVARIAN-CANCER-COALITION-ATLAS-2018.pdf) (2018)."},{"key":"818_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux, S., Braunstein, M. & Oza, A. M. Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J. Clin. 69, 280\u2013304 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"818_CR5","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1158\/1078-0432.CCR-04-2398","volume":"11","author":"A Berchuck","year":"2005","unstructured":"Berchuck, A. et al. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clin. Cancer Res. 11, 3686\u20133696 (2005).","journal-title":"Clin. Cancer Res."},{"key":"818_CR6","unstructured":"Society A. C. Cancer Facts & Figures 2020. (American Cancer Society, 2020)."},{"key":"818_CR7","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","volume":"38","author":"T Motohara","year":"2019","unstructured":"Motohara, T. et al. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment. Oncogene 38, 2885\u20132898 (2019).","journal-title":"Oncogene"},{"key":"818_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s10147-021-01866-3","volume":"26","author":"Y Iwagoi","year":"2021","unstructured":"Iwagoi, Y. et al. Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III-IV epithelial ovarian cancer. Int. J. Clin. Oncol. 26, 995\u20131004 (2021).","journal-title":"Int. J. Clin. Oncol."},{"key":"818_CR9","doi-asserted-by":"publisher","unstructured":"Etzerodt, A. et al. Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer. J. Exp. Med. 217, https:\/\/doi.org\/10.1084\/jem.20191869 (2020).","DOI":"10.1084\/jem.20191869"},{"key":"818_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang, L. et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348, 203\u2013213 (2003).","journal-title":"N. Engl. J. Med."},{"key":"818_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","volume":"591","author":"S Biswas","year":"2021","unstructured":"Biswas, S. et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature 591, 464\u2013470 (2021).","journal-title":"Nature"},{"key":"818_CR12","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455\u20132465 (2012).","journal-title":"N. Engl. J. Med."},{"key":"818_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/jamaoncol.2018.6258","volume":"5","author":"ML Disis","year":"2019","unstructured":"Disis, M. L. et al. Efficacy and safety of avelumab for patients with recurrent or refractory ovarian cancer: phase 1b results from the JAVELIN Solid Tumor Trial. JAMA Oncol. 5, 393\u2013401 (2019).","journal-title":"JAMA Oncol."},{"key":"818_CR14","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1200\/JCO.2015.62.3397","volume":"33","author":"J Hamanishi","year":"2015","unstructured":"Hamanishi, J. et al. Safety and antitumor activity of anti-PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer. J. Clin. Oncol. 33, 4015\u20134022 (2015).","journal-title":"J. Clin. Oncol."},{"key":"818_CR15","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1073\/pnas.0712237105","volume":"105","author":"FS Hodi","year":"2008","unstructured":"Hodi, F. S. et al. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc. Natl Acad. Sci. USA 105, 3005\u20133010 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"818_CR16","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1073\/pnas.0830997100","volume":"100","author":"FS Hodi","year":"2003","unstructured":"Hodi, F. S. et al. Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc. Natl Acad. Sci. USA 100, 4712\u20134717 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"818_CR17","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/annonc\/mdz135","volume":"30","author":"UA Matulonis","year":"2019","unstructured":"Matulonis, U. A. et al. Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study. Ann. Oncol. 30, 1080\u20131087 (2019).","journal-title":"Ann. Oncol."},{"key":"818_CR18","doi-asserted-by":"publisher","unstructured":"De Nola, R. et al. The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: biological pathways and therapeutic implication. Int. J. Mol. Sci. 20, https:\/\/doi.org\/10.3390\/ijms20102401 (2019).","DOI":"10.3390\/ijms20102401"},{"key":"818_CR19","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41401-020-0424-4","volume":"41","author":"B Sun","year":"2020","unstructured":"Sun, B., Hyun, H., Li, L. T. & Wang, A. Z. Harnessing nanomedicine to overcome the immunosuppressive tumor microenvironment. Acta Pharm. Sin. 41, 970\u2013985 (2020).","journal-title":"Acta Pharm. Sin."},{"key":"818_CR20","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.7150\/jca.20314","volume":"8","author":"DL Cai","year":"2017","unstructured":"Cai, D. L. & Jin, L. P. Immune cell population in ovarian tumor microenvironment. J. Cancer 8, 2915\u20132923 (2017).","journal-title":"J. Cancer"},{"key":"818_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fmed.2018.00085","volume":"5","author":"G Stanta","year":"2018","unstructured":"Stanta, G. & Bonin, S. Overview on Clinical Relevance of Intra-Tumor Heterogeneity. Front. Med.5, 85 (2018.","journal-title":"Front. Med."},{"key":"818_CR22","doi-asserted-by":"publisher","first-page":"107502","DOI":"10.1016\/j.celrep.2020.03.066","volume":"31","author":"S Lee","year":"2020","unstructured":"Lee, S. et al. Molecular analysis of clinically defined subsets of high-grade serous ovarian cancer. Cell Rep. 31, 107502 (2020).","journal-title":"Cell Rep."},{"key":"818_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"AM Patch","year":"2015","unstructured":"Patch, A. M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489\u2013494 (2015).","journal-title":"Nature"},{"key":"818_CR24","doi-asserted-by":"publisher","first-page":"923194","DOI":"10.3389\/fimmu.2022.923194","volume":"13","author":"Y Deng","year":"2022","unstructured":"Deng, Y. et al. Single-cell RNA-sequencing atlas reveals the tumor microenvironment of metastatic high-grade serous ovarian carcinoma. Front. Immunol. 13, 923194 (2022).","journal-title":"Front. Immunol."},{"key":"818_CR25","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41388-021-02139-z","volume":"41","author":"T Kan","year":"2022","unstructured":"Kan, T. et al. Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence. Oncogene 41, 895\u2013906 (2022).","journal-title":"Oncogene"},{"key":"818_CR26","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","volume":"26","author":"B Izar","year":"2020","unstructured":"Izar, B. et al. A single-cell landscape of high-grade serous ovarian cancer. Nat. Med. 26, 1271\u20131279 (2020).","journal-title":"Nat. Med."},{"key":"818_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","volume":"13","author":"S Olbrecht","year":"2021","unstructured":"Olbrecht, S., et al. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification. Genome Med. 13, 111 (2021).","journal-title":"Genome Med."},{"key":"818_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12964-022-00991-4","volume":"20","author":"RF Carvalho","year":"2022","unstructured":"Carvalho, R. F.et al. Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer. Cell Commun. Signal 20, 176 (2022).","journal-title":"Cell Commun. Signal"},{"key":"818_CR29","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","volume":"28","author":"J Xu","year":"2022","unstructured":"Xu, J. et al. Single-cell RNA sequencing reveals the tissue architecture in human high-grade serous ovarian cancer. Clin. Cancer Res. 28, 3590\u20133602 (2022).","journal-title":"Clin. Cancer Res."},{"key":"818_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41467-022-28389-3","volume":"13","author":"IM Launonen","year":"2022","unstructured":"Launonen, I. M. et al. Single-cell tumor-immune microenvironment of BRCA1\/2 mutated high-grade serous ovarian cancer. Nat. Commun. 13, 835 (2022).","journal-title":"Nat. Commun."},{"key":"818_CR31","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/bioinformatics\/btz625","volume":"36","author":"K Polanski","year":"2020","unstructured":"Polanski, K. et al. BBKNN: fast batch alignment of single cell transcriptomes. Bioinformatics 36, 964\u2013965 (2020).","journal-title":"Bioinformatics"},{"key":"818_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/jhg.2008.5","volume":"54","author":"T Shiina","year":"2009","unstructured":"Shiina, T., Hosomichi, K., Inoko, H. & Kulski, J. K. The HLA genomic loci map: expression, interaction, diversity and disease. J. Hum. Genet. 54, 15\u201339 (2009).","journal-title":"J. Hum. Genet."},{"key":"818_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati, G. S. et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science 367, 405\u2013411 (2020).","journal-title":"Science"},{"key":"818_CR34","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"818_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Single-cell mRNA quantification and differential analysis with census. Nat. Methods 14, 309\u2013315 (2017).","journal-title":"Nat. Methods"},{"key":"818_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"818_CR37","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1158\/2159-8290.CD-21-1658","volume":"12","author":"D Hao","year":"2022","unstructured":"Hao, D. et al. The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma. Cancer Discov. 12, 2626\u20132645 (2022).","journal-title":"Cancer Discov."},{"key":"818_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02371-y","author":"Y Chu","year":"2023","unstructured":"Chu, Y. et al. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-023-02371-y (2023).","journal-title":"Nat. Med."},{"key":"818_CR39","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li, H., et al. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell 176, 775\u2013789.e18 (2019).","journal-title":"Cell"},{"key":"818_CR40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fimmu.2014.00548","volume":"5","author":"E Carnero","year":"2014","unstructured":"Carnero, E. et al. Type I interferon regulates the expression of long non-coding RNAs. Front Immunol. 5, 548 (2014).","journal-title":"Front Immunol."},{"key":"818_CR41","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2015.12.032","volume":"164","author":"S Mostafavi","year":"2016","unstructured":"Mostafavi, S. et al. Parsing the interferon transcriptional network and its disease associations. Cell 164, 564\u2013578 (2016).","journal-title":"Cell"},{"key":"818_CR42","doi-asserted-by":"publisher","unstructured":"Padariya, M. et al. Functional interfaces, biological pathways, and regulations of interferon-related DNA damage resistance signature (IRDS) genes. Biomolecules 11, https:\/\/doi.org\/10.3390\/biom11050622 (2021).","DOI":"10.3390\/biom11050622"},{"key":"818_CR43","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","volume":"612","author":"I Vazquez-Garcia","year":"2022","unstructured":"Vazquez-Garcia, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778\u2013786 (2022).","journal-title":"Nature"},{"key":"818_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"818_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281\u2013291.e9 (2019).","journal-title":"Cell Syst."},{"key":"818_CR46","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","volume":"39","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell 39, 1578\u20131593.e8 (2021).","journal-title":"Cancer Cell"},{"key":"818_CR47","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.1038\/s41598-019-41695-z","volume":"9","author":"VA Traag","year":"2019","unstructured":"Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well-connected communities. Sci. Rep. 9, 5233 (2019).","journal-title":"Sci. Rep."},{"key":"818_CR48","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S., et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809.e23 (2021).","journal-title":"Cell"},{"key":"818_CR49","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med. 24, 978\u2013985 (2018).","journal-title":"Nat. Med."},{"key":"818_CR50","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng, C., et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169, 1342\u20131356.e16 (2017).","journal-title":"Cell"},{"key":"818_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"818_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"818_CR53","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"818_CR54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"818_CR55","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen, V., Lange, M., Peidli, S., Wolf, F. A. & Theis, F. J. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat. Biotechnol. 38, 1408\u20131414 (2020).","journal-title":"Nat. Biotechnol."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00818-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00818-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00818-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T03:02:17Z","timestamp":1745550137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-025-00818-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["818"],"URL":"https:\/\/doi.org\/10.1038\/s41698-025-00818-8","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.K.S. is a consultant for Merck, GSK, Astra Zeneca, ImmunoGen, Iylon, Onxeo and DSMB for Advenchen and Mural Oncology. N.D.F. is a consultant for GlaxoSmithKline and Immunogen. S.P.S. reports research funding from AstraZeneca and Bristol Myers Squibb, outside the scope of this work; S.P.S. is a consultant and shareholder of Canexia Health Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"120"}}